Celtic Biotech's leading compound in early trials has a novel mechanism of action
which has a particular affinity for targeting cancerous cells and by-passing healthy ones
Copyright © 2024 Celtic Biotech - All Rights Reserved.
We would like to use cookies to analyse website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.